Aster DM Healthcare has received approval for acquisition of additional 13% shares in Dr. Ramesh Cardiac & Multispecialty Hospital, subsidiary (DRCM). The company had entered into a Shareholders Agreement (SHA) with DRCM and its Promoter and Promoter Group on April 30, 2016. In accordance with the terms of Put Option in SHA, the promoter group of DRCM has exercised their right to sell a collective 13% stake by issuing a Put notice dated March 5, 2025.
With this acquisition, the shareholding of the company in DRCM increases from 57.49% to 70.49%. Cost of Acquisition is Rs 63.01 crore. The said acquisition is expected to be completed within the next 1–2 months. The Investment and Finance committee at its meeting held on July 30, 2025, inter alia, approved the same.
Aster DM Healthcare operates in multiple segments of the healthcare industry, including hospitals, clinics and retail pharmacies and provide healthcare services to patients across economic segments in several GCC states through its various brands ‘Aster’, ‘Medcare’ and ‘Access’.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 7699.05 |
| Max Healthcare Inst | 1006.90 |
| Narayana Hrudayalay | 1825.55 |
| Aster DM Healthcare | 688.30 |
| Global Health | 1089.55 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: